Levey, A. S. et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39, 1–266 (2002).
Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1–150 (2013).
Bagheri, B. et al. Sodium‐glucose cotransporter 2 inhibitors: a comprehensive review from cells to bedside. Fundam. Clin. Pharmacol. 37, 481–492 (2023).
Article CAS PubMed Google Scholar
Parfianowicz, D. et al. Finerenone: a new era for mineralocorticoid receptor antagonism and cardiorenal protection. Curr. Probl. Cardiol. 47, 101386 (2022).
Fakhouri, F., Schwotzer, N., Golshayan, D. & Frémeaux-Bacchi, V. The rational use of complement inhibitors in kidney diseases. Kidney Int. Rep. 7, 1165–1178 (2022).
Article PubMed Central PubMed Google Scholar
Zhang, Z., Xu, Q. & Huang, L. B cell depletion therapies in autoimmune diseases: monoclonal antibodies or chimeric antigen receptor-based therapy? Front. Immunol. 14, 1126421 (2023).
Article CAS PubMed Central PubMed Google Scholar
Salvadori, M. & Tsalouchos, A. Innovative immunosuppression in kidney transplantation: a challenge for unmet needs. World J. Transpl. 12, 27–41 (2022).
Sánchez-Álvarez, E. et al. Survival with low- and high-flux dialysis. Clin. Kidney J. 14, 1915–1923 (2021).
Blankestijn, P. J. et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N. Engl. J. Med. 389, 700–709 (2023).
Article CAS PubMed Google Scholar
Bello, A. K. et al. Epidemiology of peritoneal dialysis outcomes. Nat. Rev. Nephrol. 18, 779–793 (2022).
Article PubMed Central PubMed Google Scholar
Lewis, A. et al. Organ donation in the US and Europe: the supply vs demand imbalance. Transpl. Rev. 35, 100585 (2021).
O’Hare, A. M. Patient-centered care in renal medicine: five strategies to meet the challenge. Am. J. Kidney Dis. 71, 732–736 (2018).
Kellum, J. A. et al. Acute kidney injury. Nat. Rev. Dis. Prim. 7, 52 (2021).
Pouwels, X. G. L. V. et al. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease. eClinicalMedicine 68, 102414 (2024).
Article PubMed Central PubMed Google Scholar
Yeo, S. C., Wang, H., Ang, Y. G., Lim, C. K. & Ooi, X. Y. Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review. Clin. Kidney J. 17, sfad137 (2023).
Article PubMed Central PubMed Google Scholar
Ekrikpo, U. et al. Epidemiology and outcomes of glomerular diseases in low- and middle-income countries. Semin. Nephrol. 42, 151316 (2022).
Mapes, D. L. et al. Health-related quality of life in the dialysis outcomes and practice patterns study (DOPPS). Am. J. Kidney Dis. 44, 54–60 (2004).
Lloveras, J., Arcos, E., Comas, J. & Crespo, M. et al. A paired survival analysis comparing hemodialysis and kidney transplantation from deceased elderly donors older than 65 years. Transplantation 99, 991–996 (2015).
Article CAS PubMed Google Scholar
Tonelli, M. et al. Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA Netw. Open. 1, e184852 (2018).
Article PubMed Central PubMed Google Scholar
Crews, D. C. et al. Burden, access and disparities in kidney disease. Clin. Kidney J. 12, 160–166 (2019).
Article PubMed Central PubMed Google Scholar
International Society of Nephrology. Global kidney health atlas. https://www.theisn.org/initiatives/global-kidney-health-atlas/ (accessed 27 March 2024).
Kasiske, B. L., London, W. & Ellison, M. D. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J. Am. Soc. Nephrol. 9, 2142–2147 (1998).
Article CAS PubMed Google Scholar
Malek, S. K., Keys, B. J., Kumar, S., Milford, E. & Tullius, S. G. Racial and ethnic disparities in kidney transplantation. Transpl. Int. 24, 419–424 (2011).
Daw, J. Explaining the persistence of health disparities: social stratification and the efficiency-equity trade-off in the kidney transplantation system. Am. J. Sociol. 120, 1595–1640 (2015).
Davison, S. N., Jhangri, G. S. & Koffman, J. Knowledge of and attitudes towards palliative care and hospice services among patients with advanced chronic kidney disease. BMJ Support. Palliat. Care 6, 66–74 (2016).
Köttgen, A. et al. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 101, 1126–1141 (2022).
Bergmann, C. et al. Polycystic kidney disease. Nat. Rev. Dis. Prim. 4, 50 (2018).
Bergmann, C. Genetics of autosomal recessive polycystic kidney disease and its differential diagnoses. Front. Pediatr. 5, 221 (2018).
Article PubMed Central PubMed Google Scholar
Warady, B. A. et al. Alport syndrome classification and management. Kidney Med. 2, 639–649 (2020).
Article PubMed Central PubMed Google Scholar
Živná, M. et al. Autosomal dominant tubulointerstitial kidney disease: a review. Am. J. Med. Genet. C. Semin. Med. Genet. 190, 309–324 (2022).
Article PubMed Central PubMed Google Scholar
Elliott, M. D. et al. Clinical and genetic characteristics of CKD patients with high-risk APOL1 genotypes. J. Am. Soc. Nephrol. 34, 909–919 (2023).
Wu, M. Y., Chen, Y. C., Chiu, I. J. & Wu, M. S. Genetic insight into primary glomerulonephritis. Nephrology 27, 649–657 (2022).
Article CAS PubMed Google Scholar
Chen, L. et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Hum. Mol. Genet. 29, 1745–1756 (2020).
Article CAS PubMed Central PubMed Google Scholar
Liao, L.-N. et al. Genetic risk score for risk prediction of diabetic nephropathy in Han Chinese type 2 diabetes patients. Sci. Rep. 9, 19897 (2019).
Article CAS PubMed Central PubMed Google Scholar
Genovese, G. et al. Association of Trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Article CAS PubMed Central PubMed Google Scholar
Egbuna, O. et al. Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N. Engl. J. Med. 388, 969–979 (2023).
Article CAS PubMed Google Scholar
ClinGen. Clinical domain working groups: kidney disease CDWG. https://clinicalgenome.org/working-groups/clinical-domain/clingen-kidney-disease-clinical-domain-working-group/ (2024).
Vanholder, R. et al. A policy call to address rare kidney disease in health care plans. Clin. J. Am. Soc. Nephrol. 18, 1510–1518 (2023).
Abe, S. et al. Explainable AI for estimating pathogenicity of genetic variants using large-scale knowledge graphs. Cancers 15, 1118 (2023).
Article CAS PubMed Central PubMed Google Scholar
Khan, A. et al. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat. Med. 28, 1412–1420 (2022).
Article CAS PubMed Central PubMed Google Scholar
Wei, L., Han, Y. & Tu, C. Molecular pathways of diabetic kidney disease inferred from proteomics. Diabetes Metab. Syndr. Obes. 16, 117–128 (2023).
Article CAS PubMed Central PubMed Google Scholar
Bai, Y. et al. Urinary proteome analysis of acute kidney injury in post-cardiac surgery patients using enrichment materials with high-resolution mass spectrometry. Front. Bioeng. Biotechnol. 10, 1002853 (2022).
Article PubMed Central PubMed Google Scholar
Moledina, D. G. et al. Identification and validation of urinary C
Comments (0)